| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.EJSO.2008.01.027 |
| P698 | PubMed publication ID | 18325724 |
| P2093 | author name string | Y Endo | |
| M Ohta | |||
| K Shibata | |||
| Y Kawano | |||
| A Sasaki | |||
| S Kitano | |||
| H Uchida | |||
| S Kai | |||
| K Iwaki | |||
| P433 | issue | 2 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 174-179 | |
| P577 | publication date | 2008-03-05 | |
| P1433 | published in | European Journal of Surgical Oncology | Q2345728 |
| P1476 | title | Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study | |
| P478 | volume | 35 |
| Q85125336 | (1)H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasis |
| Q36056566 | A comparison of the risk factors of intrahepatic recurrence, early recurrencen, and multiple recurrences after resection for single nodular hepatocellular carcinoma |
| Q35032965 | A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo |
| Q38337088 | Ablation for recurrent hepatocellular carcinoma: a systematic review of clinical efficacy and prognostic factors |
| Q33711636 | Application of tumor-node-metastasis staging 2002 version in locally advanced hepatocellular carcinoma: is it predictive of surgical outcome? |
| Q51506328 | CKLF-Like MARVEL Transmembrane Domain-Containing Member 3 (CMTM3) Inhibits the Proliferation and Tumorigenisis in Hepatocellular Carcinoma Cells. |
| Q82948806 | Deregulation of HIF1-alpha and hypoxia-regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue--influence of a modulated host stroma on the prognosis of HCC |
| Q41491991 | Diagnostic and prognostic significance of secretory clusterin expression in patients with hepatocellular carcinoma |
| Q26747293 | Effect of adjuvant interferon therapy on hepatitis B virus-related hepatocellular carcinoma: a systematic review |
| Q37231074 | Hepatic parenchyma resection using stapling devices: peri-operative and long-term outcome |
| Q35338422 | Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma |
| Q61807443 | Identification of the Potential Metabolic Pathways Involved in the Hepatic Tumorigenesis of Rat Diethylnitrosamine-Induced Hepatocellular Carcinoma via H NMR-Based Metabolomic Analysis |
| Q88335191 | Irregular Defects in Hepatocellular Carcinomas During the Kupffer Phase of Contrast-Enhanced Ultrasonography with Perfluorobutane Microbubbles: Pathological Features and Metastatic Recurrence After Surgical Resection |
| Q34747847 | Molecular mechanisms of action and potential biomarkers of growth inhibition of dasatinib (BMS-354825) on hepatocellular carcinoma cells |
| Q47416372 | Nomogram predicting long-term survival after the diagnosis of intrahepatic recurrence of hepatocellular carcinoma following an initial liver resection |
| Q21092852 | Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma |
| Q34364217 | Peritumoral small ephrinA5 isoform level predicts the postoperative survival in hepatocellular carcinoma |
| Q33886179 | Proline-rich tyrosine kinase 2 (Pyk2) promotes cell motility of hepatocellular carcinoma through induction of epithelial to mesenchymal transition |
| Q33995733 | Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review |
| Q44359689 | Repeat treatment for recurrent hepatocellular carcinoma: is it validated? |
| Q43154149 | Successful en bloc resection of recurrent hepatocellular carcinoma directly invading the abdominal wall: a case report |
| Q41153363 | The arterial tumor enhancement pattern on contrast-enhanced computed tomography is associated with primary cancer death after radiofrequency ablation for small hepatocellular carcinoma |
| Q28477884 | The role of proline rich tyrosine kinase 2 (Pyk2) on cisplatin resistance in hepatocellular carcinoma |
Search more.